Shah Tushar 4
4 · Liquidia Corp · Filed Jul 23, 2021
Insider Transaction Report
Form 4
Liquidia CorpLQDA
Shah Tushar
CMO and Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2021-07-21+10,000→ 10,000 totalExercise: $2.54Exp: 2031-07-21→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on July 21, 2025; provided, however, that notwithstanding the foregoing vesting schedule, 50% of the shares of common sock underlying the option will vest upon U.S. Food and Drug Administration (FDA) tentative approval of the Issuer's New Drug Application for LIQ861.